Alex Goldberg

NASDAQ Gainers Watch List: Himax Technologies, Inc. (NASDAQ:HIMX) and Cytokinetics, Incorporated (NASDAQ:CYTK) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 02/07/2014 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Himax Technologies, Inc. (NASDAQ:HIMX) and Cytokinetics, Incorporated (NASDAQ:CYTK).

Himax Technologies, Inc. (NASDAQ:HIMX) a company that designs, develops, and markets semiconductors for flat panel displays is currently up (+2.98%) on 3,546,369 shares traded after Himax Technologies, Inc. Announced to Attend Morgan Stanley Technology, Media and Telecom Conference March 3-5, 2014. Himax Technologies, Inc. (NASDAQ:HIMX) is currently up (+430.66%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Himax Technologies, Inc. (NASDAQ:HIMX)

Cytokinetics, Incorporated (NASDAQ:CYTK) a clinical-stage biopharmaceutical company that focuses on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions is currently up (+30.23%) on 3,076,257 shares traded after Cytokinetics, Incorporated Reported Fourth Quarter 2013 Financial Results. Cytokinetics, Incorporated (NASDAQ:CYTK) is currently up (+60.42%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cytokinetics, Incorporated (NASDAQ:CYTK)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com